New Rochelle, NY, United States of America

Amy Yan


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Amy Yan and Her Pioneering Contributions to Cancer Treatment

Introduction: Amy Yan, a talented inventor based in New Rochelle, NY, has made strides in the field of medicine with her innovative work on targeted therapy. Her contributions through her patent have opened new avenues in the treatment of cancer and viral infections. As a researcher at Albert Einstein College of Medicine, Amy utilizes her expertise to develop methods that enhance the delivery of therapeutic agents.

Latest Patents: Amy Yan holds a patent for "Methods of Preparing Targeted Aptamer Prodrugs." This invention outlines techniques for the selective introduction of oligonucleotides, nucleosides, or nucleoside analogs into a subject’s cells. It includes innovative methodologies for selecting targeted aptamers and the use of combinatorial aptamer libraries, proving to be a significant advancement in personalized medicine.

Career Highlights: Throughout her career, Amy has focused on integrating advanced molecular techniques with practical therapeutic applications. Her work at Albert Einstein College of Medicine has garnered attention for its potential to change how cancer and viral infections are treated. The impact of her research not only demonstrates her inventiveness but also reflects her commitment to improving patient outcomes.

Collaborations: Amy has collaborated with esteemed colleagues such as Matthew Levy and Brian Christopher Wengerter. Their joint efforts in research exemplify the importance of teamwork in driving innovation forward in the biomedical field. Collaborations like these are crucial for the validation and application of groundbreaking ideas.

Conclusion: Amy Yan stands out as a prominent figure in the landscape of modern medicine, thanks to her patent and ongoing research. Her innovative methods in the preparation of targeted aptamer prodrugs hold promise for the future of cancer therapies and invite further exploration in the realm of targeted drug delivery systems. As she continues her work at Albert Einstein College of Medicine, the scientific community eagerly anticipates her future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…